Aevi Genomic Medicine Inc. (GNMX) Dipped -9.17% or -0.02 To Price $0.21 On Tuesday


Aevi Genomic Medicine Inc. (GNMX) dipped -9.17% or -0.02 to $0.21. It is nearly 2.51 million shares traded, which is 130.89% compare to the average total volume 1.92 million. The market cap of GNMX is $13.47 million. The year to date change is -79.43%. The 52 week price range is from $0.17 to $1.93. Price of GNMX have changed 20.84% during last week. It have changed 8.79% over last month, 1.73% over last 3 months, -81.83% over last 6 months and -87.42% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 0.21. The 200-day Moving Averages for GNMX is 0.82. It is 290.48% above current price. The 52-week High is 1.93. It is 819.05% from the current price. The 52-week Low is 0.17. It is -19.05% from current price.

There are some statistics of GNMX. It is has market cap $13.47 million. The share outstanding is 64.77 million. The average volume is 1.92 million. The percent of top 15 Institution holding is 20.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -165.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -135.12%.


Tags:

Share this post